Calendar ANI Pharmaceuticals, Inc.

Equities

ANIP

US00182C1036

Market Closed - Nasdaq 04:00:00 2024-04-12 pm EDT 5-day change 1st Jan Change
66.88 USD -1.81% Intraday chart for ANI Pharmaceuticals, Inc. -1.14% +21.29%

Chart calendar ANI Pharmaceuticals, Inc.

d7ddc0b82a9a71620f8da9.dV6qZBaGGZ_K_YfMDKhcj54FuKCOBdhlZKN9O6rpcs8.DBbBU3z0Idiwme6GWfEu7cdg-9XISOFXL8UuZOyOKoMkZ_1UILFv2qutxg~de67ee515de7c9301f80ae21819afdea

Upcoming events on ANI Pharmaceuticals, Inc.

2024-04-16 Piper Sandler Spring Biopharma Symposium
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-05-21 09:00 am Annual General Meeting
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-26 Q4 2024 Earnings Release (Projected)

Past events on ANI Pharmaceuticals, Inc.

2024-03-12 02:20 pm Leerink Partners Global Biopharma Conference
2024-02-29 08:30 am Q4 2023 Earnings Call
2024-02-29 06:50 am Q4 2023 Earnings Release
2024-02-08 10:30 am Guggenheim Healthcare Talks Biotechnology Conference
2023-11-28 01:00 pm Piper Sandler Healthcare Conference
2023-11-15 10:00 am Jefferies London Healthcare Conference
2023-11-08 08:30 am Q3 2023 Earnings Call
2023-11-08 06:50 am Q3 2023 Earnings Release
2023-09-26 11:40 am Cantor Global Healthcare Conference
2023-09-12 08:30 am H.C. Wainwright Global Investment Conference
2023-08-09 08:30 am Q2 2023 Earnings Call
2023-08-09 06:50 am Q2 2023 Earnings Release
2023-06-09 08:30 am Jefferies Global Healthcare Conference
2023-05-23 09:00 am Annual General Meeting
2023-05-08 08:30 am Q1 2023 Earnings Call
2023-05-08 06:50 am Q1 2023 Earnings Release
2023-05-02 12:00 pm H.C. Wainwright BioConnect Investor Conference
2023-03-09 08:30 am Q4 2022 Earnings Call
2023-03-09 06:50 am Q4 2022 Earnings Release
2022-11-09 08:00 am Q3 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
207
210
-1.85%
208
205
1.51%
216
212
2.14%
316
308
2.89%
487
480
1.42%

534

EBITDA
Million USD
Released
Forecast
Spread
83,2
85,5
-2.74%
67,1
68,0
-1.3%
64,8
64,8
0.06%
55,9
54,1
3.26%
134
133
0.87%

140

EBIT
Million USD
Released
Forecast
Spread
16,4
26,4
-38.06%
-16,0
-11,4
-40.49%
-39,8
-17,1
-132.71%
-35,3
-34,0
-3.77%
47,0
49,5
-5.19%

51,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
3,16
13,2
-76.08%
-26,0
-20,9
-24.22%
-56,1
-28,4
-97.39%
-62,7
-61,4
-2.13%
19,9
21,8
-8.95%

28,8

Net income
Million USD
Released
Forecast
Spread
6,09
12,8
-52.39%
-22,5
-16,9
-33.42%
-42,8
-20,9
-104.75%
-49,5
-47,9
-3.32%
17,2
19,9
-13.99%

22,9

EPS
USD
Released
Forecast
Spread
0,50
1,06
-52.83%
-1,88
-1,41
-33.33%
-3,40
-0,88
-288.57%
-3,05
-2,94
-3.86%
0,85
0,92
-7.61%

1,29

Announcement Date27/02/2009/03/2115/03/2209/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
60,9
56,3
8.22%
64,5
65,0
-0.86%
73,9
72,0
2.62%
83,8
78,4
6.97%
94,2
86,1
9.4%
107
83,5
27.92%
117
99,9
16.71%
132
112
17.79%
132
125
5.38%

125


131


137


141


133

EBITDA
Million USD
Released
Forecast
Spread
16,2
16,6
-2.39%
4,27
7,70
-44.51%
9,86
9,50
3.8%
19,6
19,5
0.52%
23,3
23,2
0.56%
33,0
16,4
101.3%
34,1
22,8
49.51%
36,5
27,5
32.55%
30,2
28,3
6.59%

30,5


33,5


37,0


38,8


36,4

EBIT
Million USD
Released
Forecast
Spread
-23,7
-1,10
-2056.64%
-19,2
-9,30
-106.4%
-12,9
-9,10
-41.9%
-5,00
0,40
-1348.75%
1,82
3,10
-41.29%
9,90
-1,30
861.15%
12,4
1,96
531.79%
17,9
7,41
142.28%
6,73
7,55
-10.91%

8,86


11,7


14,5


16,2


14,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-30,9
-3,20
-864.16%
-25,9
-15,4
-68.16%
-18,8
-15,0
-25.45%
-12,2
-5,20
-135.04%
-5,73
-3,00
-90.93%
2,17
-9,30
123.28%
5,25
-5,04
204.21%
11,5
0,31
3637.34%
0,95
1,15
-17.69%

3,09


6,10


8,95


10,8


8,89

Net income
Million USD
Released
Forecast
Spread
-24,3
-2,40
-913.58%
-20,5
-11,9
-72.56%
-15,3
-11,3
-35.66%
-9,01
-4,30
-109.44%
-4,65
-2,60
-78.85%
1,03
-7,50
113.77%
5,84
-3,75
255.56%
9,53
0,38
2382.81%
0,75
0,91
-17.74%

2,40


4,81


7,09


8,55


7,02

EPS
USD
Released
Forecast
Spread
-1,72
-0,14
-1128.57%
-1,27
-0,67
-89.55%
-0,94
-0,64
-48.03%
-0,55
-0,27
-101.22%
-0,28
-0,19
-47.37%
0,06
-0,52
111.61%
0,29
-0,18
265.71%
0,45
0,04
1025%
0,04
0,07
-40%

0,12


0,26


0,41


0,50


0,33

Announcement Date15/03/2210/05/2208/08/2209/11/2209/03/2308/05/2309/08/2308/11/2329/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ANIP Stock
  4. Calendar ANI Pharmaceuticals, Inc.